Periferisk neuropati (hovedsagelig grad 1 eller 2 sensorisk neuropati) blev observeret hos 68% af patienterne på Abraxane, heraf var 10% grad 3 og ingen grad 4 (se afsnit 5. 1).
Peripheral neuropathy (mostly Grade 1 or 2 sensory neuropathy) was observed in 68% of patients on Abraxane with 10% being Grade 3, and no cases of Grade 4.